| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| HumanPheno | Abnormal palm morphology | KRT6B KMT2B DSC2 AIP NHP2 CREBBP JARID2 USF3 PIEZO2 DST BRAF KRT6C TINF2 PEX5 ASXL2 MBD5 NIPBL ZNF292 | 9.15e-08 | 521 | 44 | 18 | HP:0100871 |
| HumanPheno | Abnormal skin morphology of the palm | KRT6B DSC2 AIP NHP2 CREBBP JARID2 USF3 PIEZO2 DST BRAF KRT6C TINF2 PEX5 ASXL2 NIPBL ZNF292 | 1.31e-07 | 413 | 44 | 16 | HP:0040211 |
| HumanPheno | Regional abnormality of skin | KRT6B DSC2 AIP NHP2 WNK1 CREBBP SCYL2 JARID2 USF3 PIEZO2 DST BRAF KRT6C TINF2 PEX5 ASXL2 NIPBL ZNF292 | 1.64e-07 | 541 | 44 | 18 | HP:0011356 |
| HumanPheno | Abnormality of the plantar skin of foot | 1.29e-06 | 171 | 44 | 10 | HP:0100872 | |
| HumanPheno | Palmoplantar hyperkeratosis | 1.12e-05 | 129 | 44 | 8 | HP:0000972 | |
| HumanPheno | Palmar hyperkeratosis | 1.26e-05 | 131 | 44 | 8 | HP:0010765 | |
| HumanPheno | Plantar hyperkeratosis | 1.33e-05 | 132 | 44 | 8 | HP:0007556 | |
| HumanPheno | Palmoplantar keratoderma | 4.52e-05 | 114 | 44 | 7 | HP:0000982 | |
| HumanPheno | Epidermal thickening | KRT6B DSC2 DUSP6 AIP NHP2 JARID2 USF3 DST BRAF KRT6C TINF2 PEX5 | 5.73e-05 | 379 | 44 | 12 | HP:0011368 |
| HumanPheno | White lesion of the oral mucosa | 8.53e-05 | 28 | 44 | 4 | HP:0025125 | |
| HumanPheno | Oral leukoplakia | 8.53e-05 | 28 | 44 | 4 | HP:0002745 | |
| HumanPheno | Thickened skin | KRT6B DSC2 DUSP6 AIP NHP2 JARID2 USF3 DST BRAF KRT6C TINF2 PEX5 | 1.99e-04 | 431 | 44 | 12 | HP:0001072 |
| MousePheno | abnormal ventricle myocardium morphology | 2.02e-06 | 116 | 102 | 8 | MP:0010499 | |
| MousePheno | abnormal vitelline vasculature morphology | ERBB2 SUPT20H ZNF148 UBR4 SUPT20HL2 AIP WNK1 ITGAV CREBBP BRAF | 8.20e-06 | 235 | 102 | 10 | MP:0003229 |
| MousePheno | abnormal trabecula carnea morphology | 2.19e-05 | 78 | 102 | 6 | MP:0004067 | |
| Domain | LRRC37AB_C | 1.40e-06 | 4 | 133 | 3 | IPR029423 | |
| Domain | LRRC37AB_C | 1.40e-06 | 4 | 133 | 3 | PF14914 | |
| Domain | LRRC37_N | 1.40e-06 | 4 | 133 | 3 | IPR032754 | |
| Domain | LRRC37 | 1.40e-06 | 4 | 133 | 3 | PF15779 | |
| Domain | LRRC37A/B-like | 1.40e-06 | 4 | 133 | 3 | IPR015753 | |
| Domain | LRR_8 | 3.11e-05 | 171 | 133 | 8 | PF13855 | |
| Domain | LRR_TYP | 3.98e-05 | 177 | 133 | 8 | SM00369 | |
| Domain | Leu-rich_rpt_typical-subtyp | 3.98e-05 | 177 | 133 | 8 | IPR003591 | |
| Domain | Spt20 | 5.03e-05 | 2 | 133 | 2 | IPR021950 | |
| Domain | Spt20 | 5.03e-05 | 2 | 133 | 2 | PF12090 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.21e-04 | 14 | 133 | 3 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 1.21e-04 | 14 | 133 | 3 | IPR013602 | |
| Domain | DHC_N2 | 1.21e-04 | 14 | 133 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 1.21e-04 | 14 | 133 | 3 | IPR011704 | |
| Domain | AAA_8 | 1.21e-04 | 14 | 133 | 3 | PF12780 | |
| Domain | AAA_5 | 1.21e-04 | 14 | 133 | 3 | PF07728 | |
| Domain | TF_octamer | 1.50e-04 | 3 | 133 | 2 | IPR000972 | |
| Domain | DHC_fam | 1.51e-04 | 15 | 133 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 1.51e-04 | 15 | 133 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 1.51e-04 | 15 | 133 | 3 | IPR004273 | |
| Domain | LRR_1 | 1.76e-04 | 219 | 133 | 8 | PF00560 | |
| Domain | POU | 1.85e-04 | 16 | 133 | 3 | SM00352 | |
| Domain | POU_dom | 1.85e-04 | 16 | 133 | 3 | IPR000327 | |
| Domain | Pou | 1.85e-04 | 16 | 133 | 3 | PF00157 | |
| Domain | POU_1 | 1.85e-04 | 16 | 133 | 3 | PS00035 | |
| Domain | POU_2 | 1.85e-04 | 16 | 133 | 3 | PS00465 | |
| Domain | POU_3 | 1.85e-04 | 16 | 133 | 3 | PS51179 | |
| Domain | POU | 2.23e-04 | 17 | 133 | 3 | IPR013847 | |
| Domain | MeTrfase | 2.99e-04 | 4 | 133 | 2 | IPR026113 | |
| Domain | Cyt_c1_TM_anchor_C | 4.96e-04 | 5 | 133 | 2 | IPR021157 | |
| Domain | L_dom-like | ERBB2 LRRC37A3 LRRC37A2 LRRC69 CPN2 LGR5 LRRC37A LRRC20 SLITRK5 | 5.76e-04 | 328 | 133 | 9 | IPR032675 |
| Domain | LRR | 5.97e-04 | 201 | 133 | 7 | PS51450 | |
| Domain | Leu-rich_rpt | 7.28e-04 | 271 | 133 | 8 | IPR001611 | |
| Domain | Nuc_rcpt_coact | 7.41e-04 | 6 | 133 | 2 | IPR009110 | |
| Domain | Methyltransf_12 | 7.41e-04 | 6 | 133 | 2 | IPR013217 | |
| Domain | Methyltransf_12 | 7.41e-04 | 6 | 133 | 2 | PF08242 | |
| Domain | Znf_CCCH | 7.74e-04 | 58 | 133 | 4 | IPR000571 | |
| Domain | ZF_C3H1 | 7.74e-04 | 58 | 133 | 4 | PS50103 | |
| Domain | - | 9.11e-04 | 27 | 133 | 3 | 1.10.260.40 | |
| Domain | RBD | 1.03e-03 | 7 | 133 | 2 | SM00455 | |
| Domain | RBD_dom | 1.03e-03 | 7 | 133 | 2 | IPR003116 | |
| Domain | RBD | 1.03e-03 | 7 | 133 | 2 | PS50898 | |
| Domain | Lambda_DNA-bd_dom | 1.13e-03 | 29 | 133 | 3 | IPR010982 | |
| Domain | - | 2.13e-03 | 321 | 133 | 8 | 3.80.10.10 | |
| Pathway | REACTOME_HEME_SIGNALING | 1.30e-05 | 49 | 88 | 5 | M41832 | |
| Pathway | REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION | 2.23e-05 | 27 | 88 | 4 | M26943 | |
| Pubmed | NCOA2 SUPT20H ZNF148 KMT2B UBR4 PABPC4 MYO18A POU2F1 E2F3 NUP214 TNRC6C ANKHD1 UBN2 RFX1 CREBBP PHF21A RSBN1 CPSF4 DST RBM27 DGKK SEC16A CCAR1 ZFHX3 ASXL2 NIPBL YTHDF2 NPAT RAVER1 | 2.81e-13 | 1429 | 137 | 29 | 35140242 | |
| Pubmed | NCOA2 ZNF148 KMT2B MYCBP2 BAZ2B PABPC4 SRM POU2F1 CHD9 QRICH1 AIP XPO1 UBN2 RFX1 CREBBP PHF21A ZC3H11A RBM27 CCAR1 PLAGL2 ASXL2 NIPBL ZNF292 RAVER1 | 1.00e-11 | 1103 | 137 | 24 | 34189442 | |
| Pubmed | ZNF148 KMT2B MYCBP2 ZGRF1 UBR4 NUP214 ANKHD1 RFX1 PHF21A DST SEC16A ZFHX3 ZMYM5 NPAT | 1.31e-09 | 418 | 137 | 14 | 34709266 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | NCOA2 ZNF148 KMT2B POU2F1 NUP214 UBN2 CREBBP PHF21A DUXB SEC16A ZFHX3 ASXL2 NIPBL | 1.57e-09 | 351 | 137 | 13 | 38297188 |
| Pubmed | NCOA2 ZNF148 XBP1 POU2F1 POU2F2 RFX1 CLOCK PHF21A JARID2 TSC22D1 CPSF4 CIZ1 CCAR1 PLAGL2 ZFHX3 MBNL3 ZMYM5 ZNF292 | 3.42e-09 | 808 | 137 | 18 | 20412781 | |
| Pubmed | VWF UBQLN2 KMT2B MYCBP2 UBR4 PABPC4 QRICH1 RFX1 CREBBP ZNF518A SCYL2 DST ASXL2 CCDC181 ZMYM5 | 1.38e-08 | 591 | 137 | 15 | 15231748 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | PRUNE2 UBQLN2 SPATA31E1 UBR4 MAP1LC3A NUP214 WNK1 USF3 XIRP2 STON2 PEX5 MAML2 ZMYM5 | 1.76e-08 | 430 | 137 | 13 | 35044719 |
| Pubmed | NCOA2 MAPK8IP1 VWF SUPT20H UBQLN2 MYCBP2 UBR4 CHD9 E2F3 QRICH1 AIP NHP2 CREBBP SCYL2 ARHGAP1 DST CADPS CCAR1 NIPBL ZMYM5 ZNF292 | 3.45e-08 | 1285 | 137 | 21 | 35914814 | |
| Pubmed | 1.95e-07 | 104 | 137 | 7 | 9205841 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ZNF148 BAZ2B PABPC4 NUP214 UBN2 RFX1 RSBN1 ZC3H11A SNAP91 TINF2 RBM27 SEC16A CIZ1 CCAR1 NIPBL YTHDF2 NPAT | 2.37e-07 | 954 | 137 | 17 | 36373674 |
| Pubmed | 2.38e-07 | 4 | 137 | 3 | 14566828 | ||
| Pubmed | 2.38e-07 | 4 | 137 | 3 | 22419166 | ||
| Pubmed | SUPT20H UBR4 SRM POU2F1 NUP214 QRICH1 XPO1 FCHO2 WNK1 XYLT2 ARHGAP1 ZC3H11A TINF2 LRRC20 SEC16A ASPM MAML2 NIPBL YTHDF2 ZNF292 | 2.76e-07 | 1327 | 137 | 20 | 32694731 | |
| Pubmed | NCOA2 ZNF148 KMT2B MYCBP2 ANKHD1 UBN2 RFX1 CREBBP SCYL2 ZC3H11A RBM27 SEC16A CIZ1 | 2.95e-07 | 549 | 137 | 13 | 38280479 | |
| Pubmed | ERBB2 SUPT20H ZNF148 DSC2 CHD9 TNFRSF10B ANKHD1 CREBBP PHF21A ZNF518A RSBN1 CADPS SEC16A CIZ1 ASPM TCF25 PEX5 ZFHX3 | 4.37e-07 | 1116 | 137 | 18 | 31753913 | |
| Pubmed | VWF SUPT20H MYO18A NUP214 WNK1 CREBBP TSC22D1 ZNF600 USF3 DST BRAF MBD5 | 5.56e-07 | 486 | 137 | 12 | 20936779 | |
| Pubmed | 5.95e-07 | 5 | 137 | 3 | 12887926 | ||
| Pubmed | 5.95e-07 | 5 | 137 | 3 | 16061936 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | POU6F2 ZNF148 SPI1 XBP1 POU2F1 POU2F2 E2F3 RFX1 CLOCK TSC22D1 ZC3H11A USF3 FOXD4L3 PLAGL2 ZFHX3 MBNL3 | 6.37e-07 | 908 | 137 | 16 | 19274049 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SUPT20H ZNF148 KMT2B BAZ2B NUP214 UBN2 NHP2 CLOCK PHF21A CPSF4 ZC3H11A DST TINF2 RBM27 CIZ1 CCAR1 ASXL2 NIPBL RAVER1 | 8.34e-07 | 1294 | 137 | 19 | 30804502 |
| Pubmed | DUSP6 PABPC4 E2F3 CREBBP ARHGAP1 EYS ZC3H11A DST SEC16A PLAGL2 | 8.63e-07 | 332 | 137 | 10 | 37433992 | |
| Pubmed | NCOA2 XBP1 POU2F1 POU2F2 FOXD4L6 QRICH1 AIP CREBBP PHF21A CPSF4 FOXD4L3 PLAGL2 ZFHX3 ZNF292 | 8.89e-07 | 709 | 137 | 14 | 22988430 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ZNF148 KMT2B BAZ2B POU2F1 CHD9 E2F3 UBN2 NHP2 RFX1 CIZ1 NIPBL ZNF292 NPAT | 9.27e-07 | 608 | 137 | 13 | 36089195 |
| Pubmed | SUPT20H ZNF148 KMT2B E2F3 PHF21A CPSF4 ZC3H11A RBM27 NPAT RAVER1 | 1.04e-06 | 339 | 137 | 10 | 30415952 | |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 1.23e-06 | 197 | 137 | 8 | 20811636 | |
| Pubmed | 1.27e-06 | 268 | 137 | 9 | 33640491 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | NCOA2 SUPT20H ZNF148 QRICH1 UBN2 CREBBP PHF21A ZC3H11A SEC16A YTHDF2 ZMYM5 | 1.63e-06 | 444 | 137 | 11 | 34795231 |
| Pubmed | 1.93e-06 | 282 | 137 | 9 | 23667531 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ZNF148 KMT2B MYCBP2 MYO18A POU2F1 NUP214 XPO1 RFX1 ZC3H11A BRAF SEC16A CCAR1 NIPBL RAVER1 | 2.47e-06 | 774 | 137 | 14 | 15302935 |
| Pubmed | KRT6B ZNF148 PABPC4 FCHO2 RFX1 SCYL2 ARHGAP1 RSBN1 DST SEC16A ASPM | 2.92e-06 | 472 | 137 | 11 | 38943005 | |
| Pubmed | 3.31e-06 | 225 | 137 | 8 | 12168954 | ||
| Pubmed | 4.28e-06 | 233 | 137 | 8 | 37704626 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | NCOA2 SUPT20H ZNF148 CREBBP PHF21A ZNF518A BRAF SEC16A CIZ1 ZNF292 | 4.35e-06 | 398 | 137 | 10 | 35016035 |
| Pubmed | ERBB2 DSC2 PABPC4 NUP214 XPO1 FCHO2 SCYL2 ARHGAP1 DST SEC16A SLITRK5 TCF25 YTHDF2 | 4.90e-06 | 708 | 137 | 13 | 39231216 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | NCOA2 PRUNE2 ERBB2 POU6F2 MYCBP2 CHD9 E2F3 TNRC6C UBN2 CREBBP ARFGEF3 TSC22D1 ZC3H11A USF3 CCAR1 ZFHX3 MBD5 SCGB2B2 RAVER1 | 6.41e-06 | 1489 | 137 | 19 | 28611215 |
| Pubmed | GALNT14 ERBB2 CAPN14 CEACAM5 KMT2B DUSP6 WNK1 CREBBP CEACAM1 BRAF DGKK METTL2A METTL2B | 6.80e-06 | 730 | 137 | 13 | 34857952 | |
| Pubmed | 7.03e-06 | 10 | 137 | 3 | 23064749 | ||
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 7.73e-06 | 180 | 137 | 7 | 35198878 | |
| Pubmed | DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage. | 1.14e-05 | 74 | 137 | 5 | 16625196 | |
| Pubmed | Identification of E-box factor TFE3 as a functional partner for the E2F3 transcription factor. | 1.28e-05 | 12 | 137 | 3 | 12748276 | |
| Pubmed | Proteome-wide characterization of N-glycosylation events by diagonal chromatography. | 1.39e-05 | 77 | 137 | 5 | 16944957 | |
| Pubmed | UBQLN2 MYCBP2 UBR4 PABPC4 SRM NUP214 AIP XPO1 ANKHD1 WNK1 ITGAV ARHGAP1 DST CCAR1 NIPBL YTHDF2 RAVER1 | 1.46e-05 | 1297 | 137 | 17 | 33545068 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 24680660 | ||
| Pubmed | Human Oct-1L isoform has tissue-specific expression pattern similar to Oct-2. | 1.54e-05 | 2 | 137 | 2 | 12663137 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 29562502 | ||
| Pubmed | Bacterial protein domains with a novel Ig-like fold target human CEACAM receptors. | 1.54e-05 | 2 | 137 | 2 | 33522633 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 19461083 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 30770747 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 15831936 | ||
| Pubmed | Differential dimer activities of the transcription factor Oct-1 by DNA-induced interface swapping. | 1.54e-05 | 2 | 137 | 2 | 11583619 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 34801967 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 31771949 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 26222911 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 32945392 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 31954088 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 27222248 | ||
| Pubmed | Identification of novel single-stranded DNA binding proteins recognizing octamer motif. | 1.54e-05 | 2 | 137 | 2 | 8185580 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 30321907 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 23845693 | ||
| Pubmed | CREB-binding protein regulates lung cancer growth by targeting MAPK and CPSF4 signaling pathway. | 1.54e-05 | 2 | 137 | 2 | 26628108 | |
| Pubmed | Characterization of large-scale genomic differences in the first complete human genome. | 1.54e-05 | 2 | 137 | 2 | 37403156 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 12144930 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 23264634 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 26102513 | ||
| Pubmed | Nup214 is required for CRM1-dependent nuclear protein export in vivo. | 1.54e-05 | 2 | 137 | 2 | 16943420 | |
| Pubmed | Silencing of E2F3 suppresses tumor growth of Her2+ breast cancer cells by restricting mitosis. | 1.54e-05 | 2 | 137 | 2 | 26512919 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 29760215 | ||
| Pubmed | Physical and functional interactions between the transcription factor PU.1 and the coactivator CBP. | 1.54e-05 | 2 | 137 | 2 | 10050886 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 25499223 | ||
| Pubmed | Genetic Heterogeneity of HER2 Amplification and Telomere Shortening in Papillary Thyroid Carcinoma. | 1.54e-05 | 2 | 137 | 2 | 27775641 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 8156594 | ||
| Pubmed | Significance of serum tumor marker levels in peritoneal carcinomatosis of appendiceal origin. | 1.54e-05 | 2 | 137 | 2 | 22941175 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 15905509 | ||
| Pubmed | 1.70e-05 | 39 | 137 | 4 | 1676977 | ||
| Pubmed | 1.85e-05 | 285 | 137 | 8 | 34369648 | ||
| Pubmed | 2.00e-05 | 83 | 137 | 5 | 28794006 | ||
| Pubmed | 2.11e-05 | 14 | 137 | 3 | 9373155 | ||
| Pubmed | Gene expression in the developing mouse retina by EST sequencing and microarray analysis. | 2.21e-05 | 142 | 137 | 6 | 11812828 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | NCOA2 SUPT20H ZGRF1 E2F3 AIP UBN2 WNK1 CREBBP ARFGEF3 SEC16A ASPM | 2.28e-05 | 588 | 137 | 11 | 38580884 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | KRT6B MYCBP2 UBR4 SRM NUP214 XPO1 ANKHD1 NHP2 CREBBP ZC3H11A DST UGDH SEC16A ASPM CCAR1 NIPBL YTHDF2 | 2.49e-05 | 1353 | 137 | 17 | 29467282 |
| Pubmed | 2.51e-05 | 87 | 137 | 5 | 12465718 | ||
| Pubmed | PRUNE2 SPI1 ZGRF1 ERVMER34-1 EYS ZC3H11A USF3 DNAH12 ZFHX3 DNAH6 RAVER1 | 2.87e-05 | 603 | 137 | 11 | 11181995 | |
| Pubmed | 2.99e-05 | 222 | 137 | 7 | 37071664 | ||
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | UBR4 NUP214 XPO1 ARHGAP1 ZC3H11A DST CADPS UGDH SEC16A RAVER1 | 3.00e-05 | 498 | 137 | 10 | 36634849 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | MYCBP2 PABPC4 MYO18A ANKHD1 UBN2 ARHGAP1 RBM27 UGDH CCAR1 YTHDF2 ZNF292 RAVER1 | 3.14e-05 | 724 | 137 | 12 | 36232890 |
| Pubmed | 3.24e-05 | 152 | 137 | 6 | 38360978 | ||
| Pubmed | NUP214 TNRC6C ARFGEF3 RSBN1 ZC3H11A CADPS SEC16A TCF25 ASXL2 | 3.61e-05 | 407 | 137 | 9 | 12693553 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | NCOA2 ZNF148 UBR4 POU2F1 POU2F2 QRICH1 ANKHD1 NHP2 RFX1 CREBBP PHF21A ZC3H11A ASXL2 | 3.64e-05 | 857 | 137 | 13 | 25609649 |
| Pubmed | Two parallel pathways mediate cytoplasmic localization of the dioxin (aryl hydrocarbon) receptor. | 4.61e-05 | 3 | 137 | 2 | 12065584 | |
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 29357356 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 31910438 | ||
| Pubmed | The ubiquitous octamer-binding protein Oct-1 contains a POU domain with a homeo box subdomain. | 4.61e-05 | 3 | 137 | 2 | 2905684 | |
| Pubmed | Clinical evaluation of the simultaneous determination of CA 15-3, CA 125 and sHER2 in breast cancer. | 4.61e-05 | 3 | 137 | 2 | 17852076 | |
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 27114368 | ||
| Pubmed | Serum concentrations of CA 125, CA 15-3, CA 19-9 and CEA in normal pregnancy: a longitudinal study. | 4.61e-05 | 3 | 137 | 2 | 21792548 | |
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 15796964 | ||
| Pubmed | Positive regulation of the vHNF1 promoter by the orphan receptors COUP-TF1/Ear3 and COUP-TFII/Arp1. | 4.61e-05 | 3 | 137 | 2 | 8622679 | |
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 10490647 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 26892612 | ||
| Pubmed | Recruitment of octamer transcription factors to DNA by glucocorticoid receptor. | 4.61e-05 | 3 | 137 | 2 | 9584182 | |
| Interaction | FEV interactions | NCOA2 SUPT20H ZNF148 KMT2B POU2F1 UBN2 RFX1 CREBBP PHF21A ZFHX3 ASXL2 NIPBL | 9.55e-09 | 203 | 132 | 12 | int:FEV |
| Interaction | CEBPA interactions | NCOA2 ZNF148 KMT2B SPI1 MYCBP2 BAZ2B PABPC4 SRM POU2F1 CHD9 QRICH1 AIP XPO1 UBN2 RFX1 CREBBP PHF21A ZC3H11A RBM27 CCAR1 PLAGL2 ASXL2 NIPBL ZNF292 RAVER1 | 4.57e-07 | 1245 | 132 | 25 | int:CEBPA |
| Interaction | KLF8 interactions | NCOA2 SUPT20H ZNF148 KMT2B POU2F1 XPO1 UBN2 CREBBP PHF21A SEC16A NIPBL YTHDF2 | 1.78e-06 | 329 | 132 | 12 | int:KLF8 |
| Interaction | PHF21A interactions | KMT2B MYCBP2 ZGRF1 UBR4 NUP214 ANKHD1 CLOCK PHF21A DST SEC16A ZFHX3 NPAT | 2.74e-06 | 343 | 132 | 12 | int:PHF21A |
| Interaction | CELF1 interactions | PABPC4 TNRC6C ANKHD1 CPSF4 ZC3H11A RBM27 UGDH CIZ1 CCAR1 YTHDF2 RAVER1 | 3.14e-06 | 288 | 132 | 11 | int:CELF1 |
| Interaction | NUP43 interactions | KMT2B BAZ2B CHD9 NUP214 UBN2 GRM7 PHF21A ZNF518A RSBN1 DST CIZ1 ZFHX3 ASXL2 NIPBL ZNF292 NPAT | 3.40e-06 | 625 | 132 | 16 | int:NUP43 |
| Interaction | SP7 interactions | NCOA2 ZNF148 KMT2B POU2F1 RFX1 CREBBP CPSF4 RBM27 CCAR1 NIPBL RAVER1 | 5.27e-06 | 304 | 132 | 11 | int:SP7 |
| Interaction | AP2B1 interactions | ERBB2 MAP1LC3A XPO1 TNRC6C FCHO2 WNK1 SCYL2 BRAF SNAP91 STON2 SEC16A PEX5 | 6.44e-06 | 373 | 132 | 12 | int:AP2B1 |
| Interaction | SOX2 interactions | NCOA2 ZNF148 DSC2 BAZ2B UBR4 PABPC4 POU2F1 CHD9 NUP214 XPO1 ANKHD1 UBN2 NHP2 RFX1 CLOCK ITIH1 SCYL2 ARHGAP1 CPSF4 SEC16A ZFHX3 NIPBL YTHDF2 ZNF292 | 1.59e-05 | 1422 | 132 | 24 | int:SOX2 |
| Interaction | TERF2IP interactions | NCOA2 ZNF148 KMT2B XPO1 RFX1 CREBBP ZC3H11A TINF2 RBM27 CIZ1 CCAR1 NIPBL ZNF292 NPAT | 1.61e-05 | 552 | 132 | 14 | int:TERF2IP |
| Interaction | EGR2 interactions | 1.72e-05 | 171 | 132 | 8 | int:EGR2 | |
| Interaction | CREM interactions | 2.80e-05 | 90 | 132 | 6 | int:CREM | |
| Interaction | TLE3 interactions | NCOA2 BAZ2B QRICH1 UBN2 CLOCK CREBBP CCAR1 ZFHX3 ASXL2 NIPBL RAVER1 | 3.80e-05 | 376 | 132 | 11 | int:TLE3 |
| Interaction | CRX interactions | 4.59e-05 | 254 | 132 | 9 | int:CRX | |
| Interaction | MEX3A interactions | DUSP6 PABPC4 E2F3 CREBBP ARHGAP1 EYS ZC3H11A DST SEC16A PLAGL2 YTHDF2 | 4.60e-05 | 384 | 132 | 11 | int:MEX3A |
| Interaction | SPATA1 interactions | 4.82e-05 | 31 | 132 | 4 | int:SPATA1 | |
| Interaction | BAG2 interactions | NCOA2 POU2F1 QRICH1 ANKHD1 UBN2 WNK1 RFX1 CREBBP SCYL2 RBM27 LRRC20 CIZ1 MBNL3 RAVER1 | 5.91e-05 | 622 | 132 | 14 | int:BAG2 |
| Interaction | FHL2 interactions | POU6F2 E2F3 QRICH1 WNK1 RFX1 CREBBP PHF21A RBM27 CCAR1 ASXL2 RAVER1 | 6.06e-05 | 396 | 132 | 11 | int:FHL2 |
| Interaction | NRBP2 interactions | 6.25e-05 | 64 | 132 | 5 | int:NRBP2 | |
| Interaction | PAN3 interactions | 6.73e-05 | 65 | 132 | 5 | int:PAN3 | |
| Interaction | CEACAM6 interactions | 7.00e-05 | 34 | 132 | 4 | int:CEACAM6 | |
| Interaction | SNRNP40 interactions | KRT6B KMT2B BAZ2B QRICH1 AIP XPO1 UBN2 PHF21A RSBN1 CIZ1 CCAR1 ZFHX3 NPAT RAVER1 | 7.62e-05 | 637 | 132 | 14 | int:SNRNP40 |
| Interaction | HNF4A interactions | 8.46e-05 | 275 | 132 | 9 | int:HNF4A | |
| Interaction | RHOQ interactions | DSC2 MYO18A TNFRSF10B FCHO2 LGR5 ITGAV SCYL2 ARFGEF3 ARHGAP1 DST SLITRK5 | 1.60e-04 | 442 | 132 | 11 | int:RHOQ |
| Interaction | CNOT2 interactions | 1.74e-04 | 178 | 132 | 7 | int:CNOT2 | |
| Interaction | KCNA3 interactions | NCOA2 ERBB2 DSC2 PABPC4 MYO18A CHD9 NUP214 XPO1 FCHO2 SCYL2 ARHGAP1 DST SEC16A SLITRK5 TCF25 YTHDF2 | 1.87e-04 | 871 | 132 | 16 | int:KCNA3 |
| Interaction | DUSP2 interactions | 1.92e-04 | 81 | 132 | 5 | int:DUSP2 | |
| Interaction | FOXJ2 interactions | 1.92e-04 | 81 | 132 | 5 | int:FOXJ2 | |
| Interaction | SOX7 interactions | 2.04e-04 | 82 | 132 | 5 | int:SOX7 | |
| Cytoband | 12q22-q23 | 2.65e-05 | 3 | 137 | 2 | 12q22-q23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p23 | 8.91e-05 | 149 | 137 | 5 | chr2p23 | |
| Cytoband | 11p11.2 | 1.16e-04 | 83 | 137 | 4 | 11p11.2 | |
| GeneFamily | Dyneins, axonemal | 7.71e-05 | 17 | 90 | 3 | 536 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 7.71e-05 | 17 | 90 | 3 | 486 | |
| GeneFamily | POU class homeoboxes and pseudogenes | 1.97e-04 | 23 | 90 | 3 | 523 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 5.06e-04 | 7 | 90 | 2 | 1299 | |
| GeneFamily | Zinc fingers CCCH-type | 6.96e-04 | 35 | 90 | 3 | 73 | |
| GeneFamily | Zinc fingers CXXC-type|Methyl-CpG binding domain containing | 1.31e-03 | 11 | 90 | 2 | 1025 | |
| GeneFamily | CD molecules|C-type lectin domain family|Killer cell lectin like receptors | 1.57e-03 | 12 | 90 | 2 | 621 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | NCOA2 SUPT20H ZNF148 MYCBP2 BAZ2B CHD9 E2F3 XPO1 CLOCK CREBBP PHF21A JARID2 RSBN1 DST ZFHX3 NIPBL ZNF292 NPAT | 4.91e-07 | 856 | 136 | 18 | M4500 |
| Coexpression | GSE16385_MONOCYTE_VS_MACROPHAGE_DN | 1.06e-06 | 200 | 136 | 9 | M7901 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 3.97e-06 | 300 | 136 | 10 | M8702 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | ZNF148 MYCBP2 BAZ2B CHD9 E2F3 XPO1 CLOCK CREBBP PHF21A JARID2 DST ZNF292 | 6.00e-06 | 466 | 136 | 12 | M13522 |
| Coexpression | GSE25123_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DN | 1.02e-05 | 200 | 136 | 8 | M7909 | |
| Coexpression | DESCARTES_FETAL_STOMACH_SQUAMOUS_EPITHELIAL_CELLS | 2.61e-05 | 67 | 136 | 5 | M40299 | |
| Coexpression | GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN | 2.65e-05 | 166 | 136 | 7 | M6826 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | BAZ2B CHD9 QRICH1 ANKHD1 WNK1 CREBBP RBM27 PEX5 PLAGL2 ZFHX3 UPK3A | 3.37e-05 | 467 | 136 | 11 | M1347 |
| Coexpression | GSE37532_WT_VS_PPARG_KO_LN_TREG_UP | 3.85e-05 | 176 | 136 | 7 | M8952 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | BAZ2B CHD9 QRICH1 ANKHD1 WNK1 CREBBP RBM27 PEX5 PLAGL2 ZFHX3 UPK3A | 4.66e-05 | 484 | 136 | 11 | MM999 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | ERBB2 SUPT20H LRRC37A2 CHD9 UBN2 ITGAV RFX1 TIAM2 ZNF518A ARHGAP1 RSBN1 TSC22D1 ZFHX3 ZMYM5 | 8.13e-05 | 807 | 136 | 14 | M16651 |
| Coexpression | GSE41867_NAIVE_VS_DAY15_LCMV_EFFECTOR_CD8_TCELL_DN | 8.63e-05 | 200 | 136 | 7 | M9472 | |
| Coexpression | GSE11924_TH2_VS_TH17_CD4_TCELL_DN | 8.63e-05 | 200 | 136 | 7 | M3165 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | ZNF148 MYCBP2 UBR4 DUSP6 POU2F2 AIP XPO1 TNRC6C WNK1 CREBBP JARID2 ZC3H11A TINF2 RBM27 ASXL2 NIPBL KLRC2 ZMYM5 ZNF292 NPAT | 8.88e-05 | 1492 | 136 | 20 | M40023 |
| ToppCell | COVID-19_Mild-NK_CD56bright|COVID-19_Mild / Disease condition and Cell class | 1.33e-06 | 179 | 136 | 7 | 90e7a4af195aa2332b07a9f06cde63e72ff49255 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.72e-06 | 186 | 136 | 7 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-06 | 188 | 136 | 7 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-06 | 191 | 136 | 7 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-06 | 191 | 136 | 7 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-06 | 191 | 136 | 7 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | medial-Hematologic-Nonclassical_Monocyte|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.27e-06 | 194 | 136 | 7 | ac203d388a3a3884e316dec0dcbd408e43c6ef6c | |
| ToppCell | medial-2-Hematologic-Nonclassical_Monocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.27e-06 | 194 | 136 | 7 | 202e5070728191c46161fa7d931f00be1c7559d4 | |
| ToppCell | medial-Hematologic-Nonclassical_Monocyte-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.27e-06 | 194 | 136 | 7 | 002cd317732fc6b0d9a72fb46199f71db5a638a7 | |
| ToppCell | LPS-antiTNF-Endothelial-Epi-like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.40e-06 | 144 | 136 | 6 | 75b16adfbe84f69376e6566d531ba7919d5c5192 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l4|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.22e-05 | 166 | 136 | 6 | 1a3a15d1fc76bb91d832cdc6e3da0a6140b94b75 | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.44e-05 | 171 | 136 | 6 | 0de81d12a8000f2c59cdb214e67dc526d18098fe | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-mature_enterocytic-Colonocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.44e-05 | 171 | 136 | 6 | 0597339618fb4d416d55c538eceb353218a55002 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-05 | 175 | 136 | 6 | c8cfe0ac0c1ac447c626a623cc49692a0b177a1c | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-05 | 175 | 136 | 6 | 61fbd8f685d3daad46449e4c0386a38886496566 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.05e-05 | 182 | 136 | 6 | 007fa56ed8b91f9af0df2114c00410b2f6cec8b6 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-05 | 187 | 136 | 6 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | Non-neuronal-Non-dividing-OPC-OPC|World / Primary Cells by Cluster | 2.54e-05 | 189 | 136 | 6 | ddf5be73912570c32c50f4ac2902da9b590526f8 | |
| ToppCell | Non-neuronal-Non-dividing-OPC|World / Primary Cells by Cluster | 2.54e-05 | 189 | 136 | 6 | 13848a031ab896b4b24c8319e4745b9b17ff9cfd | |
| ToppCell | Non-neuronal-Non-dividing-OPC-OPC-30|World / Primary Cells by Cluster | 2.54e-05 | 189 | 136 | 6 | 313d165fad541ec6e8dd524b88856e2c93eeb681 | |
| ToppCell | 10x5'-Lung-Myeloid_Monocytic-Classical_monocytes|Lung / Manually curated celltypes from each tissue | 2.61e-05 | 190 | 136 | 6 | a2574f0876ebae3a1d2a39a79cc6cadac8ee1688 | |
| ToppCell | 10x5'-Lung-Myeloid_Monocytic|Lung / Manually curated celltypes from each tissue | 2.85e-05 | 193 | 136 | 6 | ebe6be10ef5de9e1da988e263106698d3db42fce | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.85e-05 | 193 | 136 | 6 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.85e-05 | 193 | 136 | 6 | 1db487e5f81849740d57cc3e2b5739e8f7581efb | |
| ToppCell | Control-NK_CD56bright|Control / Disease condition and Cell class | 2.85e-05 | 193 | 136 | 6 | 8b1e7a226a6057e1097c1525984127b54e823876 | |
| ToppCell | COVID-19_Mild-PLT_4|World / Disease Group and Platelet Clusters | 2.85e-05 | 193 | 136 | 6 | 98a52523aa1efd5d14a2878ed106828a80a33aa2 | |
| ToppCell | normal-na-Lymphocytic_NK-NK_bright-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.94e-05 | 194 | 136 | 6 | dc4aeee379423827e8d291cffe4dbdf2ff6d0bbe | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.94e-05 | 194 | 136 | 6 | a94f9f7179a5733e3c378ff8b337e288785433a1 | |
| ToppCell | normal-na-Lymphocytic_NK-NK_bright|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.94e-05 | 194 | 136 | 6 | 8c5f716ce05c1f187de63c1b6948eb9f90ff34fe | |
| ToppCell | Myeloid-Myeloid-C_(Cd16+_Monocyte)|Myeloid / shred on cell class and cell subclass (v4) | 2.99e-05 | 117 | 136 | 5 | d1936e76a935216783a73ab414e4147fa48e68eb | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-05 | 195 | 136 | 6 | bd8e24dd598990204998d1dd853ba7a53dc0107e | |
| ToppCell | control-Myeloid-CD16_Monocytes|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.02e-05 | 195 | 136 | 6 | f398d08a23fdfa6202f73a7aeac3ff4c997fbdfd | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-05 | 196 | 136 | 6 | 00f9171da4c791619e8c4c8c3c7da578c96a30ed | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.11e-05 | 196 | 136 | 6 | b04ca69b0ed44e09c989b575f747e1e819cd8008 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.11e-05 | 196 | 136 | 6 | a31e227de2dc077b81881295b012d22fedbd65ed | |
| ToppCell | VE-NK|VE / Condition, Cell_class and T cell subcluster | 3.20e-05 | 197 | 136 | 6 | cae6ff8763501e7a5897b50188ac2640d65a47c0 | |
| ToppCell | Healthy/Control-Non-classical_Monocyte|World / Disease group and Cell class | 3.20e-05 | 197 | 136 | 6 | 470784932e1fc3ff69f27cd83f56d85b0c01af63 | |
| ToppCell | VE-NK-|VE / Condition, Cell_class and T cell subcluster | 3.20e-05 | 197 | 136 | 6 | ee89b8521fb4faaed9e4d39f7171e45eccf38b00 | |
| ToppCell | distal-1-Epithelial-Basal|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.20e-05 | 197 | 136 | 6 | 25a2ccc98b973611de0d920b1b455d0b40f0d37f | |
| ToppCell | distal-Epithelial-Basal-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.20e-05 | 197 | 136 | 6 | 75b4292ce2ad7f9c8b6a4781e1cb71f5b18b74e3 | |
| ToppCell | COVID-19_Mild-PLT_4|COVID-19_Mild / Disease Group and Platelet Clusters | 3.29e-05 | 198 | 136 | 6 | 3d8c33dba759df0974aeb2b9a6b5167ae7a18e1f | |
| ToppCell | Control-PLT_4|Control / Disease Group and Platelet Clusters | 3.29e-05 | 198 | 136 | 6 | 387fd3037fd52e4d4c42de0588767e58af228b59 | |
| ToppCell | Healthy_donor-Non-classical_Monocyte|World / disease group, cell group and cell class (v2) | 3.29e-05 | 198 | 136 | 6 | 8a97c8b2a43e6d1e669ce18752841e2006744bd9 | |
| ToppCell | Healthy_donor-Non-classical_Monocyte|Healthy_donor / disease group, cell group and cell class (v2) | 3.29e-05 | 198 | 136 | 6 | d4eae333fa100db3ea2d4cbe7a1d6ab14816f0e2 | |
| ToppCell | Healthy/Control-Non-classical_Monocyte|Healthy/Control / Disease group and Cell class | 3.29e-05 | 198 | 136 | 6 | 0badaf1fa5328d06291c3624d0f63196ffc81527 | |
| ToppCell | NS-control-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.39e-05 | 199 | 136 | 6 | 32bdfff40fd442b88489c8b0f79af3927a51a03c | |
| ToppCell | control-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.39e-05 | 199 | 136 | 6 | 3d01f90ffd271ca00129192787e4921bdca7e01e | |
| ToppCell | control-Epithelial-Secretory|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.39e-05 | 199 | 136 | 6 | 262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 5.93e-05 | 135 | 136 | 5 | 3351e8b9e417397c5fa9f856184ff24ce1a27242 | |
| ToppCell | Control-B_memory-6|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.14e-05 | 136 | 136 | 5 | 94f23bef50c0beb54ed39b1a4b340f7aec4e75cd | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-innate_lymphocytic-immature_natural_killer_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.59e-05 | 146 | 136 | 5 | 40fac8a298152ec7f7eeeed5a2d28541aea3b338 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 9.46e-05 | 149 | 136 | 5 | 768877bade04ca0321593b8470b5011ad8270431 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.10e-04 | 154 | 136 | 5 | c6ecc46b99a783373729f7fae0b23216148ffb78 | |
| ToppCell | 10x5'-Liver-Myeloid_Mac-Intestinal_macrophages|Liver / Manually curated celltypes from each tissue | 1.17e-04 | 156 | 136 | 5 | 9a897fc79c4fae94c5f2e9012d65297f9225e5e3 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.28e-04 | 159 | 136 | 5 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-04 | 162 | 136 | 5 | 484ea4ac40de672dcbd2583a52cb7f385c918814 | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-04 | 162 | 136 | 5 | bba144ac5332bab9eba2ccf599703c781a7f88f1 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.40e-04 | 162 | 136 | 5 | 0fa93efc9c005d1e649b3f7069ae8641d6e41ed8 | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-non-classical_monocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.44e-04 | 163 | 136 | 5 | bbbc3f0ce2616d07136f69ce682ba1d3790711d9 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Mesenchymal-Cilia-bearing_cell|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.48e-04 | 164 | 136 | 5 | 346e1530b4bf30adbcb2f7d64fdfb4cd8df69d7f | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.48e-04 | 164 | 136 | 5 | 11dfd84f5fb90de330858e1e852848832734e004 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EECs|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.53e-04 | 165 | 136 | 5 | 4b4e75ad0eb0a6b00c30a000ec6267e23ba2e496 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-intermediate_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-04 | 165 | 136 | 5 | e32697321cef424c2ad4e11ee9da3e510d5ce505 | |
| ToppCell | Mild-Myeloid-Mast|Mild / Condition, Lineage, Cell class and cell subclass | 1.53e-04 | 165 | 136 | 5 | 5fa9552c37890c5cc7e672a47038aebba2413cb4 | |
| ToppCell | Mild-Myeloid-Mast-|Mild / Condition, Lineage, Cell class and cell subclass | 1.53e-04 | 165 | 136 | 5 | 93d3909a0f5f43d473d5005c842d7d73e25eceed | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Intermediate_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-04 | 165 | 136 | 5 | 0fbdd043e11aa8dbff4cd3a4da1b2feb49878a09 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.57e-04 | 166 | 136 | 5 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-intermediate_monocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.66e-04 | 168 | 136 | 5 | 00cff4698db14e03ca1d1b409e5ed1ad23b12615 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.66e-04 | 168 | 136 | 5 | 4b5be7c6662eceddf90a65015f12908278d1664e | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.66e-04 | 168 | 136 | 5 | 689c41f6e9f65381570991cc311cba49a57ec955 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l4|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.71e-04 | 169 | 136 | 5 | 90c00ab30e582b0e2a2be751e1fae9024cfb9ea6 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Rorb-Excitatory_Neuron.Slc17a7-Slc17a6.Rorb-Pcdh20_(Layer_5a)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.74e-04 | 91 | 136 | 4 | 1fa597c5fa4523b18fa386ee19237b82778bb1cb | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l4|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.75e-04 | 170 | 136 | 5 | 4d28dc9eb572f43809619f923978cd7494853d43 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-04 | 170 | 136 | 5 | 8e774af244cfe787fa0ea2b6be0c3c2d00bfe4fc | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-04 | 170 | 136 | 5 | f5140eb9313c0d1bb31f8a761d9c062c56733a61 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-intermediate_monocyte|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.80e-04 | 171 | 136 | 5 | ed5886d6aa87b2d73469d39dc217227bd4d4c918 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-non-classical_monocyte|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.80e-04 | 171 | 136 | 5 | 00739085fdbc4d64c9faacba2c2adeab580dd2b1 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.85e-04 | 172 | 136 | 5 | 5f58ff6cac32546d07b2a49ed250b6c7aa417188 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-I_cells_(CCK+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.85e-04 | 172 | 136 | 5 | 2651dece87c3e3d2d6370f5274ebae357474b825 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Mesenchymal-Cilia-bearing_cell|5w / Sample Type, Dataset, Time_group, and Cell type. | 1.90e-04 | 173 | 136 | 5 | d4cbeae262abfa30d8c5452285d3261a96875610 | |
| ToppCell | IIH-CD8-naive_CD4|IIH / Condition, Cell_class and T cell subcluster | 1.90e-04 | 173 | 136 | 5 | 4f2843371d18af766c1892529ce286f56c956fde | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-04 | 175 | 136 | 5 | 5c38d4b6c03473d841e6203a7efaa6dcb2d59386 | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-Tuft-related-Microfold_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.01e-04 | 175 | 136 | 5 | 8a37b2811f39bb9baa537e8755a29d559eb8185a | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.06e-04 | 176 | 136 | 5 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | (9)_Platelet|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.11e-04 | 177 | 136 | 5 | 0830944c43de300815831a9e2b2fce40965e7d12 | |
| ToppCell | (9)_Platelet|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.11e-04 | 177 | 136 | 5 | e63d01c7fce4fa1256212fa7e95f74281edb3a01 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.11e-04 | 177 | 136 | 5 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.17e-04 | 178 | 136 | 5 | a95bb77a2c2ce7c38989e6f971812f7ee9f5bd4b | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-4|TCGA-Breast / Sample_Type by Project: Shred V9 | 2.17e-04 | 178 | 136 | 5 | 44b5ba4e8788d3973749a1717e427647ac4c8579 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-intermediate_monocyte|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.17e-04 | 178 | 136 | 5 | a1f2c134bb7596f678fb4cc11405c374d926ea0f | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.17e-04 | 178 | 136 | 5 | 8151e5d73407fd9cba382b69a2bc707c81790c7f | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.23e-04 | 179 | 136 | 5 | 859cd8ee414ad6207c046ada2e655e49322dd01c | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.29e-04 | 180 | 136 | 5 | 1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Dendritic-DC1|lymph-node_spleen / Manually curated celltypes from each tissue | 2.29e-04 | 180 | 136 | 5 | a7db1f00566c9acab8b239cbf2e053fb3f2f6a0d | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.29e-04 | 180 | 136 | 5 | 3dc80bc636bf0e6ffc9762853132a9fe59fd1f66 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.29e-04 | 180 | 136 | 5 | 668a2d8e1d5a390309d5eb62c836f5903144bea9 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Basal-Basal|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.34e-04 | 181 | 136 | 5 | 6b43dcaeeb02ad5900772b6f16f1581847050e38 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Basal|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.34e-04 | 181 | 136 | 5 | f50561fdacfb83ba85fe6476e7cbc2bad1ebc826 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-04 | 182 | 136 | 5 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-04 | 185 | 136 | 5 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | NCOA2 CHD9 E2F3 CREBBP JARID2 RSBN1 ASPM PLAGL2 NIPBL ZNF292 NPAT | 1.14e-08 | 184 | 133 | 11 | 2321_DN |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.27e-06 | 182 | 133 | 9 | 3887_DN | |
| Drug | Succimer | ZMYND15 NCOA2 VWF ZNF148 DSC2 BAZ2B DUSP6 POU2F2 CHD9 ITGAV CREBBP ZNF518A XYLT2 ARFGEF3 TSC22D1 ZC3H11A PIEZO2 BRAF CADPS PLAGL2 MBNL3 ZNF292 | 4.01e-06 | 1264 | 133 | 22 | ctd:D004113 |
| Drug | Magnetite Nanoparticles | ZMYND15 NCOA2 VWF ZNF148 DSC2 BAZ2B DUSP6 POU2F2 CHD9 ITGAV CREBBP ZNF518A XYLT2 ARFGEF3 TSC22D1 ZC3H11A PIEZO2 BRAF CADPS PLAGL2 MBNL3 ZNF292 | 7.09e-06 | 1310 | 133 | 22 | ctd:D058185 |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 1.10e-05 | 180 | 133 | 8 | 4541_DN | |
| Drug | tyrphostin AG-825; Down 200; 25.2uM; MCF7; HT_HG-U133A_EA | 1.35e-05 | 185 | 133 | 8 | 1114_DN | |
| Disease | immunoglobulin isotype switching measurement | 1.57e-06 | 44 | 132 | 5 | EFO_0010128 | |
| Disease | Malignant neoplasm of breast | NCOA2 ERBB2 VWF PNLIPRP1 UBR4 LRRC37A2 XBP1 POU2F1 NUP214 NUDT17 WNK1 ZC3H11A LRRC37A BRAF CLCA2 NIPBL | 2.56e-05 | 1074 | 132 | 16 | C0006142 |
| Disease | Adenocarcinoma of lung (disorder) | 4.12e-05 | 206 | 132 | 7 | C0152013 | |
| Disease | immune system disease (implicated_via_orthology) | 5.94e-05 | 3 | 132 | 2 | DOID:2914 (implicated_via_orthology) | |
| Disease | coagulation factor measurement | 9.44e-05 | 20 | 132 | 3 | EFO_0004634 | |
| Disease | urate measurement, bone density | PLB1 BAZ2B E2F3 QRICH1 TIAM2 SCYL2 EYS SEC16A MAML2 DNAH8 SCGB2B2 | 1.11e-04 | 619 | 132 | 11 | EFO_0003923, EFO_0004531 |
| Disease | Cetuximab response | 1.97e-04 | 5 | 132 | 2 | cv:CN077967 | |
| Disease | Panitumumab response | 1.97e-04 | 5 | 132 | 2 | cv:CN077999 | |
| Disease | brain disease (implicated_via_orthology) | 2.94e-04 | 6 | 132 | 2 | DOID:936 (implicated_via_orthology) | |
| Disease | acute myeloid leukemia (is_implicated_in) | 5.60e-04 | 84 | 132 | 4 | DOID:9119 (is_implicated_in) | |
| Disease | Dyskeratosis congenita | 7.00e-04 | 9 | 132 | 2 | cv:C0265965 | |
| Disease | hypospadias | 7.11e-04 | 39 | 132 | 3 | EFO_0004209 | |
| Disease | HOYERAAL-HREIDARSSON SYNDROME | 8.73e-04 | 10 | 132 | 2 | C1846142 | |
| Disease | urinary 6‑hydroxymelatonin sulfate to creatinine ratio | 8.73e-04 | 10 | 132 | 2 | EFO_0021488 | |
| Disease | venous thromboembolism, von Willebrand factor measurement | 8.84e-04 | 42 | 132 | 3 | EFO_0004286, EFO_0004629 | |
| Disease | metabolite measurement, body weight gain | 1.27e-03 | 12 | 132 | 2 | EFO_0004566, EFO_0004725 | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 1.27e-03 | 12 | 132 | 2 | DOID:9119 (implicated_via_orthology) | |
| Disease | Carcinogenesis | 1.50e-03 | 13 | 132 | 2 | C0596263 | |
| Disease | glucose measurement | 1.65e-03 | 380 | 132 | 7 | EFO_0004468 | |
| Disease | monocyte percentage of leukocytes | CHD9 B3GNT7 TNFRSF10B WNK1 DNAH12 RBM27 SEC16A UBXN2A MBD5 KLRC2 | 1.70e-03 | 731 | 132 | 10 | EFO_0007989 |
| Disease | Neoplasm of lung | 1.74e-03 | 14 | 132 | 2 | cv:C0024121 | |
| Disease | Lung cancer | 1.74e-03 | 14 | 132 | 2 | cv:C0242379 | |
| Disease | LUNG CANCER | 1.74e-03 | 14 | 132 | 2 | 211980 | |
| Disease | response to methotrexate | 2.29e-03 | 16 | 132 | 2 | GO_0031427 | |
| Disease | Dyskeratosis Congenita | 2.29e-03 | 16 | 132 | 2 | C0265965 | |
| Disease | Benign neoplasm of stomach | 2.58e-03 | 17 | 132 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 2.58e-03 | 17 | 132 | 2 | C0496905 | |
| Disease | Dystonia, Limb | 2.58e-03 | 17 | 132 | 2 | C0751093 | |
| Disease | Dystonia, Diurnal | 2.58e-03 | 17 | 132 | 2 | C0393610 | |
| Disease | Carcinoma in situ of stomach | 2.58e-03 | 17 | 132 | 2 | C0154060 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 2.58e-03 | 17 | 132 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | reaction time measurement | EAPP LRRC37A2 TNRC6C PHF21A ARHGAP1 JARID2 SNAP91 CCAR1 ZFHX3 | 2.89e-03 | 658 | 132 | 9 | EFO_0008393 |
| Disease | Dystonia, Paroxysmal | 2.90e-03 | 18 | 132 | 2 | C0393588 | |
| Disease | fat body mass | 2.99e-03 | 217 | 132 | 5 | EFO_0005409 | |
| Disease | Systemic Scleroderma | 3.23e-03 | 19 | 132 | 2 | C0036421 | |
| Disease | age at onset, smoking initiation | 3.23e-03 | 19 | 132 | 2 | EFO_0004847, EFO_0005670 | |
| Disease | factor VIII measurement, Ischemic stroke | 3.23e-03 | 19 | 132 | 2 | EFO_0004630, HP_0002140 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 3.58e-03 | 139 | 132 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | prostate adenocarcinoma (is_implicated_in) | 3.58e-03 | 20 | 132 | 2 | DOID:2526 (is_implicated_in) | |
| Disease | Malignant Glioma | 3.85e-03 | 70 | 132 | 3 | C0555198 | |
| Disease | mixed gliomas | 3.85e-03 | 70 | 132 | 3 | C0259783 | |
| Disease | Stomach Carcinoma | 3.94e-03 | 21 | 132 | 2 | C0699791 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 4.07e-03 | 447 | 132 | 7 | EFO_0000694, MONDO_0100096 | |
| Disease | total blood protein measurement | 4.17e-03 | 449 | 132 | 7 | EFO_0004536 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ASNTAPLQPEQLQVF | 386 | P04626 | |
| NVTAPTPQQLQAFKN | 486 | P15056 | |
| SNNISELPPQVFSQL | 226 | P22792 | |
| QPQPQSLLQAQISAA | 241 | Q8IX12 | |
| QPQVLSQQLPFIFQS | 346 | Q9UIF8 | |
| NNQSLPVSPRLQLSN | 181 | P06731 | |
| QSLPVSPRLQLSNDN | 361 | P06731 | |
| LPERISPLQANNQQQ | 276 | Q969M2 | |
| QILPNAQLVFSDPSQ | 606 | Q0JRZ9 | |
| SPSSPQQQQQVLNIL | 2076 | Q92793 | |
| SRQQQPVPNSDAVLN | 166 | Q56P03 | |
| QLPSFQQNQNVPLLS | 231 | Q5VUY2 | |
| QQQSNQVFPSLSLIP | 41 | Q6UX39 | |
| TPAQNNLLQPNFEAA | 686 | O60641 | |
| NLPSSLGQFQQLVQD | 246 | Q569K6 | |
| PFPLFLQQVQSDTAQ | 151 | Q02487 | |
| SVNPILSPNQFLKDN | 386 | Q8IZT6 | |
| RQNLLSVVPPSQFNF | 1076 | Q76L83 | |
| ADLDALQQNPQPLIF | 136 | O00170 | |
| ASPQQPQQDFEALLA | 21 | A8MX76 | |
| VANLPPSLTQQQFEE | 136 | Q8IY67 | |
| NEQPTLQSSAQLLLQ | 676 | Q9P2N5 | |
| LQSPSPSQLQAAQIQ | 156 | Q2TAL8 | |
| NVAENFSISNPAPQQ | 881 | Q9UPP5 | |
| NPLFLQQPVISTQQE | 231 | Q6ZNQ3 | |
| LQTPPRSNSVFAVNQ | 906 | Q14207 | |
| LTSNLPNVNLPNVNL | 1011 | Q9ULU8 | |
| NSPQNLNNPSNEILA | 4506 | Q8WXI7 | |
| ALPANAILNQFQPAA | 391 | Q13310 | |
| APQPQLDFQDSQESL | 1056 | Q5KSL6 | |
| NQSLLTPLNLQIDPA | 141 | P48668 | |
| SSLQQEAPAQLPQLL | 236 | O60309 | |
| LNPQNNISLEFQTFS | 1901 | Q5T1H1 | |
| SSLQQEAPAQLPQLL | 236 | A6NM11 | |
| SSLQQEAPAQLPQLL | 236 | A6NMS7 | |
| DFQLEVTPQNITLNP | 741 | P19827 | |
| QLQARIQPNPNEVSA | 196 | P0C025 | |
| LFPQVPRSQDTLNNN | 166 | Q9UQF2 | |
| LINSQFPFPQITNNE | 2876 | Q03001 | |
| ASQQFLEQSLQPGLQ | 46 | Q6VB84 | |
| SQPLNLALSPQQSAQ | 521 | Q9H9K5 | |
| NQSLLTPLNLQIDPA | 141 | P04259 | |
| NENPNNFQILLLSDP | 61 | P54315 | |
| QNPATQNAPRLLQDS | 951 | Q92614 | |
| FLQDQNAPLVSRAPQ | 66 | P50542 | |
| PPQEASNRLQIFQAS | 1226 | Q96JB1 | |
| LFTEFPELAPSQNQN | 96 | Q6P1Q9 | |
| SQQEQTAFLPANQVP | 421 | Q6KC79 | |
| TAFLPANQVPVLQQN | 426 | Q6KC79 | |
| IPPSLNQRVELFQLN | 1716 | Q6ZR08 | |
| PLPQSENKLQTAQQQ | 76 | Q96BD5 | |
| TPNLFQLPQQTQGAL | 141 | P09086 | |
| SLLEEQQSAQLPQAP | 1516 | P35658 | |
| PQTQAQLLQPLQALQ | 731 | Q9UMN6 | |
| RNQFQDFPEQLTALP | 106 | Q8TCA0 | |
| VLIQDINDNPPTFSQ | 121 | Q9Y5G1 | |
| INDNPPTFSQNITEL | 126 | Q9Y5G1 | |
| FLNPQNLSLLTSNPV | 676 | P14859 | |
| LFTEFPELAPSQNQN | 96 | Q96IZ6 | |
| QNNQETPNLKLSPCA | 436 | Q96FL9 | |
| SQQFSQRAVAPPNQL | 1006 | Q8IZL2 | |
| PNQLSTQILPNLNQS | 1051 | Q8IZL2 | |
| PINNANSTENDPQQL | 241 | Q5TID7 | |
| LNPNTSLNSNNFQIL | 326 | Q3L8U1 | |
| NPQEQFSENNALDLP | 416 | Q711Q0 | |
| TQPGLLETFQNNNAL | 1156 | Q9C0G6 | |
| ASPANLLQQTEDQIP | 401 | O00716 | |
| NNQSLPVSPRLQLSN | 181 | P13688 | |
| QIQILPDQTFTALQP | 2126 | Q5TH69 | |
| PILNQFTPANISRQA | 606 | P06756 | |
| QPLNLGQFDISNILQ | 311 | A0A1W2PPF3 | |
| QQALTNLQLPQPAFI | 291 | Q9NUK0 | |
| PLNQILNQHNAASFP | 561 | Q9P267 | |
| LDQINSDPNLLPNVT | 86 | Q14831 | |
| QSNNPPLQRSSSLIQ | 191 | O95639 | |
| TENPFDLLDFNQTQP | 211 | P00742 | |
| NPTNLLEFLADRQPQ | 246 | Q8NFL0 | |
| ILNVTPNLPNLFENA | 236 | Q16828 | |
| ELLVNQNPIAQPLAS | 26 | Q9NX24 | |
| SSLPQTVCNQLPNLQ | 341 | O75473 | |
| LQAQRKFAQSQPNSP | 111 | Q92833 | |
| PPASELNLQQDQKTQ | 761 | Q5VWQ0 | |
| LNSSQPSLRAQVPQF | 1101 | Q9HCJ0 | |
| QVPQFLSPQVQAQLL | 1111 | Q9HCJ0 | |
| NFIENPPDLNDSNQA | 401 | Q8WUY3 | |
| IVLIPFLEQNNFSPN | 91 | P26717 | |
| LQLTNIQVPQQALPT | 161 | P22670 | |
| LQVQPITPQLLTNAQ | 366 | P78424 | |
| ASQQFLEQSLQPGLQ | 46 | Q3SYB3 | |
| PLPNQQFGVSLQHLQ | 236 | Q07960 | |
| PLSIENNLNLNQFNS | 576 | Q6P3W7 | |
| SQAEDTQQALLPSQP | 666 | Q6ZUB1 | |
| GNLPLQIQSNEQSFL | 2226 | O75592 | |
| IVLIPFLEQNNSSPN | 91 | Q07444 | |
| RFPTLTNINENNPTL | 436 | P03915 | |
| TNINENNPTLLNPIK | 441 | P03915 | |
| FQIPAQRLFNPSTNL | 206 | Q92561 | |
| APLQQVQAQLSPLQN | 171 | P17861 | |
| PPQSLNLLSQAQLQA | 81 | Q15714 | |
| NLLSQAQLQAQPLAP | 86 | Q15714 | |
| PLIATNTNLPLAQQI | 876 | Q15714 | |
| AENNFTELQSVQPPQ | 66 | P17947 | |
| NQLKPLPAVAFNVNN | 971 | Q9BVR0 | |
| TLQQNFLLGNSSLNP | 361 | Q9BZV3 | |
| VQPFFQNTLTPLNER | 1321 | Q6P1J6 | |
| LQLNPTQAFFLLVNQ | 71 | Q9H492 | |
| AQPLLTTLQAQPQDS | 446 | Q9UPG8 | |
| ATNPFLNETLQDVQP | 311 | Q8WXE9 | |
| LSTQGQAFPAQQLLN | 696 | P0C7V6 | |
| DNQDTSNLPQLAVPA | 2116 | Q8IWZ3 | |
| AQLTQPPQQFLQTSR | 776 | O15516 | |
| AINPQVPENQNLISN | 46 | Q9UQC9 | |
| NFNNVPDLELNPIRS | 46 | Q96BS2 | |
| QLATPNLQQFFPQAT | 141 | Q9ULV3 | |
| DDLQNSQLPQLFPDT | 811 | Q15596 | |
| LPIDQASFASQNRQP | 1041 | Q15596 | |
| LNPINFNPENNVKES | 2096 | A4UGR9 | |
| ANTKPNLNLQVLSNP | 146 | O60701 | |
| SLNPGNPVNNQIFLQ | 961 | O14980 | |
| QTNPVVKLSNNPQLS | 951 | Q6ZU65 | |
| FTPQNNEFQLQLSPK | 2061 | P04275 | |
| PPNQSQLLEEFLDNF | 1001 | Q8IVF5 | |
| LSNPESLPAQGQAQN | 1081 | O15027 | |
| FDPVPNLQLLFLNNN | 501 | O94991 | |
| NDQLQLNNVLLTFPP | 176 | A6NJ88 | |
| ALPTPQAQQLQDVLS | 161 | Q9BSI4 | |
| QQNKLSVQSNPSPQL | 121 | O75152 | |
| PEQSLPQQRFQLSSA | 711 | Q8NEM7 | |
| LPNENQTNIPFNELN | 1016 | Q9H5I5 | |
| NLSAVPLNNLEPITN | 161 | P68543 | |
| AVNLQQPQQSTFNPE | 1431 | O60281 | |
| LQPQLASVTFATNNP | 21 | O75631 | |
| PQTISLNGQLFALQP | 661 | Q68DE3 | |
| STNFQEPVQPLTQQQ | 256 | P19623 | |
| ITQQDLAPQQRAAPQ | 56 | O14763 | |
| QSQQASEFLPPEVNQ | 771 | Q6AHZ1 | |
| QNFQPTAQQQLTKPA | 226 | Q9UJ78 | |
| NSNLFSEDAQPQPFI | 701 | Q86YA3 | |
| PSLNFVTDNQTLPNQ | 626 | Q9UQR1 | |
| LNSPLFTANPQLQEQ | 411 | Q9UHD9 | |
| NFNISNLQKSISNPP | 2361 | Q9H4A3 | |
| NPSPLTEESFLNVQQ | 51 | Q4G0G5 | |
| NLQNTLLQQLGVAPF | 726 | Q5T4S7 | |
| NNSPNSSLLPQKQEV | 141 | Q6ZNG1 | |
| PQSFPELNIQNKQSL | 496 | Q9H091 | |
| NDNSNIPNSELLPFL | 156 | Q499Y3 | |
| NAEISQPPALSQLVN | 486 | Q9BQ70 | |
| QSFQGLSSILNLPQP | 776 | Q9H1B5 | |
| PAQLSVQQQAAQPTR | 336 | Q9Y5A9 | |
| QQQAALIQSQLFNPT | 1761 | Q15911 |